SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-005311
Filing Date
2021-05-13
Accepted
2021-05-13 20:34:12
Documents
1
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3954
  Complete submission text file 0001179110-21-005311.txt   5329
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Issuer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RUBIUS THERAPEUTICS 399 BINNEY STREET SUITE 300 CAMBRIDGE MA 02139
Business Address
Prener Anne (Reporting) CIK: 0001797917 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38586 | Film No.: 21921553